
Overview
Background
Professor Coral Gartner is an international expert in tobacco control policy and the world's leading expert on electronic nicotine delivery systems (or e-cigarettes). She is the Director of the NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame (Tobacco Endgame CRE), an Australian Research Council Future Fellow, and the Chair of the Interdisciplinary Tobacco Endgame Research Network, the country lead Investigator for Australia with the International Tobacco Control Policy Evaluation Project (ITC Project), and a Co-Investigator with the SewAUs Wastewater Epidemiology Project. She is currently the Director of Research at the University of Queensland's School of Public Health, the Regional Editor for Australasia for the BMJ journal, Tobacco Control, after serving as a senior editor from 2012-2018. She is the immediate Past President of the Oceania Chapter of the Society for Research on Nicotine and Tobacco (SRNT-O).
She leads a multidisciplinary research team of international experts (located in Australia, New Zealand, Canada, the USA, England, and the Netherlands) to develop the evidence base for tobacco endgame strategies and to identify the most promising policies that could end the cigarette epidemic in Australia, and beyond. Her research program includes consideration of how these policies could be implemented, while mitigating potential unintended impacts and increasing equity. Her research methods span cohort studies, clinical trials, policy analyses, simulation modelling and mixed methods research.
Professor Gartner joined the University of Queensland in 2006. With undergraduate qualifications in environmental health and a PhD in environmental epidemiology, she completed a postdoctoral fellowship on tobacco control policy and held a NHMRC Career Development Fellowship (2014-2018). In 2019, she led the development of UQ’s flagship cross-faculty postgraduate programs in Environmental Health Sciences.
Professor Gartner has published over 300 academic works, including journal articles, book chapters, and submissions to government inquiries, and has served as an expert witness to a number of government inquiries and consultations. She has also authored articles on tobacco control topics for The Conversation.
Availability
- Professor Coral Gartner is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Bachelor of Applied Science, Queensland University of Technology
- Bachelor (Honours), Queensland University of Technology
- Doctor of Philosophy, Queensland University of Technology
Works
Search Professor Coral Gartner’s works on UQ eSpace
2010
Conference Publication
How long does it take to reduce inequalities in lung cancer incidence through smoking policies?
Soerjomataram, I., Barendregt, J.J., Gartner, C., Kunst, A., Møller, H. and Avendano, M. (2010). How long does it take to reduce inequalities in lung cancer incidence through smoking policies?. 43rd Annual Meeting of the Society for Epidemiologic Research, Anaheim, CA. U.S.A., June 23-26 2010. Cary, NC, U.S.A.: Oxford University Press. doi: 10.1093/aje/kwq151
2010
Conference Publication
Tobacco Harm Reduction
Gartner, C. E. and Hall, W. D. (2010). Tobacco Harm Reduction. ANEX Australian Drugs Conference: Public Health and Harm Reduction, Melbourne, Australia, 2010.
2009
Journal Article
The potential role of snus in tobacco harm reduction
Gartner Coral and Hall, Wayne (2009). The potential role of snus in tobacco harm reduction. Addiction, 104 (9), 1586-1587. doi: 10.1111/j.1360-0443.2009.02706.x
2009
Journal Article
Predicting the future prevalence of cigarette smoking in Australia: How low can we go and by when?
Gartner, CE, Barendregt, JJ and Hall, WD (2009). Predicting the future prevalence of cigarette smoking in Australia: How low can we go and by when?. TOBACCO CONTROL, 18 (3), 183-189. doi: 10.1136/tc.2008.027615
2009
Journal Article
Direct-to-consumer genome-wide scans: Astrologicogenomics or simple scams?
Hall, Wayne and Gartner, Coral (2009). Direct-to-consumer genome-wide scans: Astrologicogenomics or simple scams?. The American Journal of Bioethics, 9 (6-7), 54-56. doi: 10.1080/15265160902894021
2009
Journal Article
Smokeless tobacco use in Australia
Gartner, CE and Hall, WD (2009). Smokeless tobacco use in Australia. Drug and Alcohol Review, 28 (3), 284-291. doi: 10.1111/j.1465-3362.2009.00058.x
2009
Journal Article
Supping with the Devil? The role of law in promoting tobacco harm reduction using low nitrosamine smokeless tobacco products
Hall, W and Gartner, C (2009). Supping with the Devil? The role of law in promoting tobacco harm reduction using low nitrosamine smokeless tobacco products. Public Health, 123 (3), 287-291. doi: 10.1016/j.puhe.2008.12.018
2009
Journal Article
Multiple genetic tests for susceptibility to smoking do not outperform simple family history
Gartner, Coral E., Barendregt, Jan and Hall, Wayne D. (2009). Multiple genetic tests for susceptibility to smoking do not outperform simple family history. Addiction, 104 (1), 118-126. doi: 10.1111/j.1360-0443.2008.02392.x
2009
Conference Publication
Modelling the impacts of high-, low- and no-tech approaches to ending the smoking epidemic
Gartner, C.E. (2009). Modelling the impacts of high-, low- and no-tech approaches to ending the smoking epidemic. Oceania Tobacco Control Conference, Darwin, Australia, 2009.
2009
Conference Publication
Australian smokers' interest in using low nitrosamine smokeless tobacco products
Gartner, Coral E., Jimenez, Eliana and Hall, Wayne D. (2009). Australian smokers' interest in using low nitrosamine smokeless tobacco products. 2009 Joint Conference of SRNT and SRNT-Europe, Saggart, Co. Dublin, Ireland, 27-30 April 2009. SRNT (Society for Research on Nicotine and Tobacco).
2009
Other Outputs
Australia
Hall, W. D. and Gartner, C. E. (2009). Australia.
2008
Journal Article
Five genetic variants associated with prostate cancer
Gartner, Coral E., Barendregt, Jan J. and Hall, Wayne D. (2008). Five genetic variants associated with prostate cancer. New England Journal of Medicine, 358 (25), 2738-2739. doi: 10.1056/NEJMc080680
2008
Journal Article
The genetics of nicotine addiction liability: Ethical and social policy implications
Hall, Wayne D., Gartner, Coral E. and Carter, Adrian (2008). The genetics of nicotine addiction liability: Ethical and social policy implications. Addiction, 103 (3), 350-359. doi: 10.1111/j.1360-0443.2007.02070.x
2008
Journal Article
Should Australia lift its ban on low nitrosamine smokeless tobacco products?
Gartner, Coral E. and Hall, Wayne D. (2008). Should Australia lift its ban on low nitrosamine smokeless tobacco products?. Medical Journal of Australia, 188 (1), 44-46. doi: 10.5694/j.1326-5377.2008.tb01505.x
2008
Book Chapter
Smokeless tobacco and harm reduction
Gartner, C. E. (2008). Smokeless tobacco and harm reduction. Tobacco in Australia: Facts and issues: A comprehensive online resource. (pp. 39-41) edited by M. H. Winstanley and M. M. Scollo. Melbourne, Vic., Australia: Cancer Council Victoria.
2008
Conference Publication
Screening for genetic susceptibility to smoking
Gartner, C. E. (2008). Screening for genetic susceptibility to smoking. The University of Queensland School of Population Health seminar, Brisbane, Queensland, Australia, March 2008.
2007
Journal Article
Swedish snus for tobacco harm reduction – Authors' reply
Gartner, Coral E., Hall, Wayne D., Vos, Theo, Bertram, Melanie Y. and Wallace, Angela L. (2007). Swedish snus for tobacco harm reduction – Authors' reply. The Lancet, 370 (9594), 1206-1207. doi: 10.1016/S0140-6736(07)61532-3
2007
Journal Article
Should the health community promote smokeless tobacco (snus) as a harm reduction measure?
Gartner, C. E., Hall, W. D., Chapman, S. and Freeman, B. (2007). Should the health community promote smokeless tobacco (snus) as a harm reduction measure?. PLoS Medicine, 4 (7), 1138-1141. doi: 10.1371/journal.pmed.0040185
2007
Journal Article
RE: Does snus use have a harm reduction effect in Sweden?
Gartner, C. E. and Hall, W. D. (2007). RE: Does snus use have a harm reduction effect in Sweden?. Tobacco Control, eletters.
2007
Journal Article
RE: Does Snus use have a harm reduction effect in Sweden?
Gartner, Coral E. and Hall, Wayne D. (2007). RE: Does Snus use have a harm reduction effect in Sweden?. Tobacco Control, eletters.
Funding
Current funding
Past funding
Supervision
Availability
- Professor Coral Gartner is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Available projects
-
Projects related to tobacco control policy and smoking cessation
Tobacco smoking is the leading cause of preventable death globally, killing over 7 million people per year. In Australia, smoking causes 20,933 deaths per year, accounting for nearly 1 in 7 deaths and 9% of disease burden. Discussion is growing about how to end the cigarette epidemic, meaning reducing smoking prevalence to a level that is no longer a major public health issue. Once seen as ‘unthinkable’, this goal is now part of mainstream tobacco control research and government health policy. A range of endgame strategies have been proposed; some have been implemented or are under serious consideration in other countries. The NHMRC-funded Centre of Research Excellence on Achieving the Tobacco Endgame (Tobacco Endgame CRE) will develop the evidence base for and outline a roadmap for Australia to end smoking in Australia.
Please note, I am currently only considering inquiries from PhD applicants with relevant track records in tobacco control policy or smoking cessation research or practice, particularly those with experience/knowledge of the Australian situation.
Aboriginal and Torres Strait Islander candidates are especially encouraged to apply.
-
Research on ending the tobacco smoking epidemic in Australia
Tobacco smoking is the leading cause of preventable death globally, killing over 7 million people per year. In Australia, smoking causes 20,933 deaths per year, accounting for nearly 1 in 7 deaths and 9% of disease burden. Discussion is growing about how to end the cigarette epidemic, meaning reducing smoking prevalence to a level that is no longer a major public health issue. Once seen as ‘unthinkable’, this goal is now part of mainstream tobacco control research and government health policy. A range of endgame strategies have been proposed; some have been implemented or are under serious consideration in other countries. The NHMRC-funded Centre of Research Excellence on Achieving the Tobacco Endgame (Tobacco Endgame CRE) will develop the evidence base for and outline a roadmap for Australia to end smoking in Australia.
Preferred educational background: Undergraduate Class I or IIA honours or Masters degree in Public Health, Health Sciences, Chemistry, Behavioural Sciences, Biostatistics, Epidemiology, Environmental Health, Regulatory Science, Health Law, Health Policy, Political Science, Business, Economics, Communications, Psychology or a related field. Knowledge and experience in health policy or product regulation would be highly valued. Applicants must have excellent academic track records. Relevant experience in tobacco control related research or practice will be highly valued.
If you are interested in one of these topics, please contact Professor Gartner to discuss. Aboriginal and Torres Strait Islander candidates are especially encouraged to apply.
-
Projects related to tobacco control policy and smoking cessation
Tobacco smoking is the leading cause of preventable death globally, killing over 7 million people per year. In Australia, smoking causes nearly 21,000 deaths per year, accounting for nearly 1 in 7 deaths and 9% of disease burden. Discussion is growing about how to end the cigarette epidemic, meaning reducing smoking prevalence to a level that is no longer a major public health issue. Once seen as ‘unthinkable’, this goal is now part of mainstream tobacco control research and government health policy. A range of endgame strategies have been proposed; some have been implemented or are under serious consideration in other countries. The NHMRC-funded Centre of Research Excellence on Achieving the Tobacco Endgame (Tobacco Endgame CRE) is developing the evidence base for a roadmap for how Australia can reduce smoking to very low levels to end the large preventable disease burden.
Please note, I am currently only considering inquiries from domestic PhD applicants or international applicants with very strong relevant track records in tobacco control policy or smoking cessation research or practice, particularly those with experience/knowledge of the Australian situation.
Aboriginal and Torres Strait Islander candidates are especially encouraged to apply.
Supervision history
Current supervision
-
Doctor Philosophy
The Tobacco Endgame: The legal framework to end the tobacco epidemic in Australia
Principal Advisor
Other advisors: Associate Professor Bernadette Richards
-
Doctor Philosophy
Exploring Civil and Criminal Litigation and Policy Frameworks of Australia's Tobacco Industry
Principal Advisor
-
Doctor Philosophy
The Tobacco Endgame: The legal framework to end the tobacco epidemic in Australia
Principal Advisor
Other advisors: Associate Professor Bernadette Richards
-
Doctor Philosophy
The availability and use of illicit tobacco and nicotine vaping products in Australia
Principal Advisor
Other advisors: Dr Cheneal Puljevic
-
Doctor Philosophy
Smoking Cessation in People with a Serious Mental Illness
Principal Advisor
Other advisors: Professor Dan Siskind, Professor Steve Kisely
-
Doctor Philosophy
The Illicit Tobacco Market in Australia
Associate Advisor
Other advisors: Dr Cheneal Puljevic
-
Doctor Philosophy
Support for Commercial Tobacco Endgame Policies among People Who Experience Tobacco-Related Stigma
Associate Advisor
Other advisors: Associate Professor Henry Marshall, Associate Professor Bernadette Richards, Dr Kylie Morphett
-
Doctor Philosophy
Understanding drivers and deterrents of Australia's illicit tobacco market
Associate Advisor
Other advisors: Dr Cheneal Puljevic
-
Doctor Philosophy
Digital Deterrence: Exploring innovative social media interventions to curtail youth vaping
Associate Advisor
Other advisors: Professor Jason Connor, Dr Carmen Lim
-
Doctor Philosophy
Regulating the design and construction of nicotine and tobacco products
Associate Advisor
Other advisors: Dr Kylie Morphett
-
Doctor Philosophy
Evaluating the Public Health Impacts of Vaping Product Use
Associate Advisor
Other advisors: Professor Jason Connor, Emeritus Professor Wayne Hall, Associate Professor Janni Leung, Associate Professor Gary Chung Kai Chan
-
Doctor Philosophy
Expansion of smoking bans into contentious spaces and the tobacco endgame
Associate Advisor
Other advisors: Dr Kylie Morphett
-
Doctor Philosophy
Determinants of alcohol drinking, and tobacco smoking, and e-cigarette vaping in Vietnamese young people and young Vietnamese migrant in Australia : implications for public health interventions and substance-use control policies
Associate Advisor
Other advisors: Professor Jason Connor, Associate Professor Phong Thai, Associate Professor Gary Chung Kai Chan
Completed supervision
-
2024
Doctor Philosophy
The Impact of Tobacco Tax Increases on Smoking Behaviours and Tobacco Purchasing Patterns
Principal Advisor
Other advisors: Associate Professor Gary Chung Kai Chan
-
2022
Doctor Philosophy
Appraisal of a regional smoking cessation campaign in Central Queensland: The '10,000 Lives' Initiative
Principal Advisor
Other advisors: Professor Sheleigh Lawler
-
2019
Doctor Philosophy
Exploring the role of vaporised nicotine as a harm reduction approach amongst people living with HIV who smoke
Principal Advisor
Other advisors: Dr Peter Baker, Associate Professor Judith Dean
-
2018
Doctor Philosophy
Evaluation and Development of Smoking Cessation and Tobacco Harm Reduction Information Sources for People with Mental Illness: A Multiple Methods Approach
Principal Advisor
Other advisors: Professor Pauline Ford
-
Doctor Philosophy
The biomedicalisation of smoking cessation: A mixed methods study of lay perspectives on nicotine addiction
Principal Advisor
Other advisors: Emeritus Professor Wayne Hall
-
2024
Doctor Philosophy
Evaluating the Public Health Impacts of Vaping Product Use
Associate Advisor
Other advisors: Professor Jason Connor, Emeritus Professor Wayne Hall, Associate Professor Janni Leung, Associate Professor Gary Chung Kai Chan
-
2024
Doctor Philosophy
Conversational Artificial Intelligence to Support Smoking Cessation: The Co-Design Development of Quin, a Smartphone Application-based Smoking Cessation Chatbot
Associate Advisor
Other advisors: Professor Sheleigh Lawler, Associate Professor Henry Marshall
-
2023
Doctor Philosophy
Emerging trends of cannabis vaping in the USA and Canada: Prevalence, correlates, and online presence
Associate Advisor
Other advisors: Professor Jason Connor, Emeritus Professor Wayne Hall, Dr Daniel Stjepanovic, Associate Professor Janni Leung, Associate Professor Gary Chung Kai Chan
-
2022
Doctor Philosophy
Cannabis and Tobacco Use in Young Adults Who Use Amphetamine-Type Stimulants: A Population-Based Study
Associate Advisor
Other advisors: Dr Andrew Smirnov
-
2021
Doctor Philosophy
Exploring the role of health professionals in communicating health messages about nicotine vaping products to smokers: A multiple methods approach
Associate Advisor
Other advisors: Dr Kylie Morphett, Associate Professor Kathryn Steadman
-
2014
Doctor Philosophy
Measuring Population Illicit Drug Use through Wastewater Analysis: Temporal Trends, Spatial Differences and Specific Events
Associate Advisor
Other advisors: Professor Jochen Mueller
Media
Enquiries
Contact Professor Coral Gartner directly for media enquiries about:
- electronic cigarettes
- Public health - smoking reduction
- Smoking - health
- Smoking - public health policy
- Smoking - quitting
- Snus (smokeless tobacco)
- Tobacco - health
- Tobacco - snus
- vaping
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: